【24h】

Spectrophotometric, septrofluorimetric and LC determination of lisinopril.

机译:赖诺普利的分光光度法,分离荧光法和LC测定。

获取原文
获取原文并翻译 | 示例
           

摘要

Three methods are described for the determination of lisinopril in the pharmaceutical tablets. The spectrophotometric method depends on the reaction of the lisinopril with sodium hypochlorite and phenyl hydrazine to form a condensation product measured at 362 nm. The spectrophotometric method was extended to develop a stability indicating method. The spectrofluorimetric method depends on reaction of the lisinopril with o-phthalaldehyde in the presence of 2-mercaptoethanol in borate buffer pH 9.5. The fluorescence of the reaction product was measured upon excitation at a maximum of 340 nm with emission wavelength at 455 nm. The HPLC method depends on using Hypersil silica column with a mobile phase consisting of methanol-water-triethylamine (50:50:0.1 v/v) and the pH was adjusted to 2.6 with 0.1 N perchloric acid. Quantitation was achieved with UV detection at 210 nm based on peak area.
机译:描述了测定药物片剂中赖诺普利的三种方法。分光光度法取决于赖诺普利与次氯酸钠和苯基肼的反应,形成在362 nm处测得的缩合产物。扩展了分光光度法以开发一种稳定性指示方法。荧光光谱法取决于赖诺普利与邻苯二甲醛在2-巯基乙醇存在下在pH 9.5的硼酸盐缓冲液中的反应。反应产物的荧光在最大340nm处激发且发射波长在455nm处被测量。 HPLC方法取决于使用具有由甲醇-水-三乙胺(50:50:0.1 v / v)组成的流动相的Hypersil硅胶柱,并用0.1 N高氯酸将pH调节至2.6。通过基于峰面积的210 nm紫外检测实现定量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号